Continued dual antiplatelet therapy beyond 1 year postcoronary stenting benefits patients with diabetes

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Patients with diabetes are likely to benefit from additional use of dual antiplatelet therapy beyond the currently recommended 6-12 months following implantation of drug-eluting stents, although they may benefit less than those without diabetes.  

Study design

  • Prespecified an...